NSE ScannerHospitals & Diagnostics · Medical/Nursing Services · NSE: NEPHROCARE · data 2026-10-31
Nephro Care India Limited
₹81.3+3.04% on 30 OctHealth: Weak 0.2/10
Feb 2026Low ₹51.75 · High ₹112.35-17.6%
In plain words
Price: 48.0% below its 52-week high of ₹156.35.
A description of the data, not a recommendation.
Key figures
Price
₹81.3
Market cap
—
P/E
—
P/B
—
ROE
—
ROCE
—
Debt / equity
—
Dividend yield
—
1-year return
-39.0%
52-week high
₹156.35
52-week low
₹50.05
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | — |
| Profit growth, 3 years (yearly) | — |
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Common questions
What is the 52-week high and low of Nephro Care India Limited?
The 52-week high is ₹156.35 and the 52-week low is ₹50.05.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Nephro Care India Limited | ₹81.3 | — | — | — | — | — | — | -39.0% |
| Rays of Belief Limited | ₹245.16 | ₹513 cr | — | — | — | — | — | +2.6% |
| Pramodini Medicare Limited | ₹106.6 | ₹235 cr | — | — | — | — | — | -11.2% |
| Lotus Eye Hospital And Institute Ltd | ₹109.15 | ₹221 cr | 1,520.2 | — | 0.1% | -0.3% | 0.26 | -9.0% |
| Vaidya Sane Ayurved Laboratories Limited | ₹136 | ₹143 cr | 15.9 | 1.6 | 12% | 12% | 0.03 | -48.7% |
| Nidan Laboratories and Healthcare Limited | ₹13 | ₹18 cr | 12 | — | 2.2% | 4% | 0.16 | -33.3% |
Compare NEPHROCARE with MOMSBELIEF in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open NEPHROCARE in NSE Scanner →